Cubicin (daptomycin recalls
The FDA has published 6 recalls involving Cubicin (daptomycin since 2014. The latest was reported on 10 Nov 2021. Most were for particulate matter. Cubist Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2014
Last 12 months0reported
Class I583% of total
Ongoing0latest 10 Nov 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 5 83%Class II 1 17%Class III 0 0%
Why cubicin (daptomycin is recalled
Companies
By year
All cubicin (daptomycin recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Cubicin (daptomycin for injection), 500 mg per vial recalled | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Cubicin (daptomycin) in NS, Packaged as a) 350MG recalled | Sentara Enterprises | Sterility | NC, VA |
| Drug | CLASS I | Cubicin (daptomycin for injection) 500 mg, For Intravenous Use Only recalled | Cubist Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS I | Cubicin (daptomycin for injection), 500 mg single-use vial recalled | Cubist Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS I | Cubicin (daptomycin for injection), 500 mg single-use vial recalled | Cubist Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS I | Cubicin (daptomycin for injection) recalled by Cubist Pharmaceuticals | Cubist Pharmaceuticals | Particulate Matter | Nationwide |
Should you stop taking Cubicin (daptomycin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.